300 related articles for article (PubMed ID: 18274074)
41. What is the best proton energy for accelerator-based BNCT using the 7Li(p,n)7Be reaction?
Allen DA; Beynon TD
Med Phys; 2000 May; 27(5):1113-8. PubMed ID: 10841417
[TBL] [Abstract][Full Text] [Related]
42. Measurement of neutron spectra generated from bombardment of 4 to 24 MeV protons on a thick ⁹Be target and estimation of neutron yields.
Paul S; Sahoo GS; Tripathy SP; Sharma SC; Ramjilal ; Ninawe NG; Sunil C; Gupta AK; Bandyopadhyay T
Rev Sci Instrum; 2014 Jun; 85(6):063501. PubMed ID: 24985813
[TBL] [Abstract][Full Text] [Related]
43. [Neutron pollution in roentgen beams from electron accelerators].
Fehrentz D; Hassib GM; Spyropoulos B
Strahlentherapie; 1983 Nov; 159(11):703-12. PubMed ID: 6658859
[TBL] [Abstract][Full Text] [Related]
44. Analysis of Neutron Production in Passively Scattered Ion-Beam Therapy.
Heo S; Yoo S; Song Y; Kim E; Shin J; Han S; Jung W; Nam S; Lee R; Lee K; Cho S
Radiat Prot Dosimetry; 2017 Jul; 175(3):297-303. PubMed ID: 27885084
[TBL] [Abstract][Full Text] [Related]
45. Development of a compact proton scanning system in Uppsala with a moveable second magnet.
Lorin S; Grusell E; Tilly N; Medin J; Blom M; Ziemann V; Reistad D; Glimelius B
Phys Med Biol; 2000 May; 45(5):1151-63. PubMed ID: 10843097
[TBL] [Abstract][Full Text] [Related]
46. The photon sensitivity of a moderated activation neutron detector.
McGinley PH
Med Phys; 1986; 13(5):700-2. PubMed ID: 3784999
[TBL] [Abstract][Full Text] [Related]
47. Shielding design for a laser-accelerated proton therapy system.
Fan J; Luo W; Fourkal E; Lin T; Li J; Veltchev I; Ma CM
Phys Med Biol; 2007 Jul; 52(13):3913-30. PubMed ID: 17664585
[TBL] [Abstract][Full Text] [Related]
48. Comparison of whole-body phantom designs to estimate organ equivalent neutron doses for secondary cancer risk assessment in proton therapy.
Moteabbed M; Geyer A; Drenkhahn R; Bolch WE; Paganetti H
Phys Med Biol; 2012 Jan; 57(2):499-515. PubMed ID: 22217682
[TBL] [Abstract][Full Text] [Related]
49. Monte Carlo simulation of secondary neutron dose for scanning proton therapy using FLUKA.
Lee C; Lee S; Lee SJ; Song H; Kim DH; Cho S; Jo K; Han Y; Chung YH; Kim JS
PLoS One; 2017; 12(10):e0186544. PubMed ID: 29045491
[TBL] [Abstract][Full Text] [Related]
50. Investigating in-field and out-of-field neutron contamination in high-energy medical linear accelerators based on the treatment factors of field size, depth, beam modifiers, and beam type.
Biltekin F; Yeginer M; Ozyigit G
Phys Med; 2015 Jul; 31(5):517-23. PubMed ID: 25873196
[TBL] [Abstract][Full Text] [Related]
51. Proton beam scattering system optimization for clinical and research applications.
Wroe AJ; Schulte RW; Barnes S; McAuley G; Slater JD; Slater JM
Med Phys; 2013 Apr; 40(4):041702. PubMed ID: 23556872
[TBL] [Abstract][Full Text] [Related]
52. Neutron Radiation Dose Measurements in a Scanning Proton Therapy Room: Can Parents Remain Near Their Children During Treatment?
Mares V; Farah J; De Saint-Hubert M; Domański S; Domingo C; Dommert M; Kłodowska M; Krzempek K; Kuć M; Martínez-Rovira I; Michaś E; Mojżeszek N; Murawski Ł; Ploc O; Romero-Expósito M; Tisi M; Trompier F; Van Hoey O; Van Ryckeghem L; Wielunski M; Harrison RM; Stolarczyk L; Olko P
Front Oncol; 2022; 12():903706. PubMed ID: 35912238
[TBL] [Abstract][Full Text] [Related]
53. A study of neutron radiation quality with a tissue-equivalent proportional counter for a low-energy accelerator-based in vivo neutron activation facility.
Aslam ; Waker AJ
Radiat Prot Dosimetry; 2011 Feb; 143(2-4):467-70. PubMed ID: 21183541
[TBL] [Abstract][Full Text] [Related]
54. [Neutron Dosimetry System Using CR-39 for High-energy X-ray Radiation Therapy].
Yabuta K; Monzen H; Tamura M; Tsuruta T; Itou T; Nohtomi A; Nishimura Y
Igaku Butsuri; 2014; 34(3):139-48. PubMed ID: 26288880
[TBL] [Abstract][Full Text] [Related]
55. Secondary neutron dose during proton therapy using spot scanning.
Schneider U; Agosteo S; Pedroni E; Besserer J
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):244-51. PubMed ID: 12007965
[TBL] [Abstract][Full Text] [Related]
56. On-line monitoring of radiotherapy beams: experimental results with proton beams.
Litzenberg DW; Roberts DA; Lee MY; Pham K; Vander Molen AM; Ronningen R; Becchetti FD
Med Phys; 1999 Jun; 26(6):992-1006. PubMed ID: 10436901
[TBL] [Abstract][Full Text] [Related]
57. The determination of a dose deposited in reference medium due to (p,n) reaction occurring during proton therapy.
Dawidowska A; Ferszt MP; Konefał A
Rep Pract Oncol Radiother; 2014 May; 19(Suppl):S3-S8. PubMed ID: 28443192
[TBL] [Abstract][Full Text] [Related]
58. Patient neutron dose equivalent exposures outside of the proton therapy treatment field.
Polf JC; Newhauser WD; Titt U
Radiat Prot Dosimetry; 2005; 115(1-4):154-8. PubMed ID: 16381704
[TBL] [Abstract][Full Text] [Related]
59. Variations in proton scanned beam dose delivery due to uncertainties in magnetic beam steering.
Peterson S; Polf J; Ciangaru G; Frank SJ; Bues M; Smith A
Med Phys; 2009 Aug; 36(8):3693-702. PubMed ID: 19746802
[TBL] [Abstract][Full Text] [Related]
60. Bremsstrahlung and photoneutron production in a steel shield for 15-22-MeV clinical electron beams.
Fujita Y; Myojoyama A; Saitoh H
Radiat Prot Dosimetry; 2015 Feb; 163(2):148-59. PubMed ID: 24821930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
